May 11, 2020 / 7:18 AM / 21 days ago

BRIEF-4D Pharma Completes Part A Of Phase I/II Trial Of Mrx0518 In Combination With Keytruda

May 11 (Reuters) - 4D Pharma Plc:

* ANNOUNCES SUCCESSFUL COMPLETION OF PART A OF PHASE I/II TRIAL OF MRX0518 IN COMBINATION WITH KEYTRUDA

* PART B OF STUDY HAS NOW COMMENCED AND WILL ASSESS CLINICAL BENEFIT AND SAFETY

* ENROLMENT WILL BE EXPANDED TO ADDITIONAL TRIAL LOCATIONS AND SITES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below